Fingolimod – Articles Page

شرکت داروسازی ابوریحان

اطلاعات دارویی Product Information

1 FDA lable EN - دانلود
2 Fingolimod EN - دانلود

مستندات تاییدیه Approval Package

1 Administrative Document(s) & Correspondence EN - دانلود
2 Approval Letter EN - دانلود
3 Chemistry review EN - دانلود
4 Clinical Pharmacology Biopharmaceutics Review EN - دانلود
5 Cross Discipline Team Leader Review EN - دانلود
6 Medical Review EN - دانلود
7 Other Review EN - دانلود
8 Pharmacology review EN - دانلود
9 printed labeling EN - دانلود
10 Proprietary Name Review EN - دانلود
11 Risk Assessment and Risk Mitigation Review EN - دانلود
12 Risk Evaluation and Mitigation Strategy(REMS) EN - دانلود
13 Statistical review EN - دانلود
14 Summary Review EN - دانلود

مقالات مروری Review Article

1 Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis 2015 EN Dovepress دانلود
2 Fingolimod A Review of its Use in the Management of Relapsing-Remitting Multiple Sclerosis 2011 EN Scott دانلود
3 review-of-the-safety-efficacy-and-tolerability-of-fingolimo 2019 EN Dovepress دانلود

مقالات اورجینال Original Research

1 Fingolimod in the treatment of relapsing–remitting multiple sclerosis long term experience and an update on the clinical evidence 2016 EN - دانلود
2 Real-world evidence on the safety andeffectiveness of fingolimod in patients withmultiple sclerosis from Taiwan 2021 EN - دانلود